Skip to content
Head to head

Omnicell vs Veeva Systems

Side-by-side on the measures that matter, with a plain-English read. Full detail: OMCL · VEEV

Updated 9 minutes ago

1-year performance, rebased to 100

OMCL -4.9%VEEV -3.9%
Veeva Systems edges it on the scoreable measures. Veeva Systems has the highest Quant Rating (37); Veeva Systems has done best over the past year (-2%); Veeva Systems earns the most per share.
OMCLVEEV
Snapshot
SectorHealth Information ServicesHealth Information Services
Last price32.51266.22
Change today-2.02%+1.26%
1-year return-5.3%-1.6%
Market cap$1.50B$43.10B
52-week range31.75 – 55.00148.05 – 325.99
Valuation
P/E (TTM)33.8643.64
P/E percentile, own 5-yr range35th14th
P/B1.145.80
Dividend yield0.00%0.00%
Profitability & growth
EPS (TTM)0.045.44
Net profit (TTM)$1.84M$880.78M
Revenue (TTM)$1.24B$3.46B
Provider revenue period date2026-09-292026-07-30
Revenue growth (YoY)-0.9%+17.6%
Gross margin45.1%75.0%
Operating margin5.2%29.9%
Net margin3.6%29.3%
Free cash flow (TTM)$132.73M$1.67B
Provider cash-flow period date2026-09-292026-07-30
Ownership & sentiment
Institutional ownership113.0%88.0%
Insider activity (12mo)18 buy / 32 sell25 buy / 22 sell
Short interest (% of float)8.3%2.4%
Analyst consensus83% buy / 17% hold (6)74% buy / 22% hold / 4% sell (23)
Analyst price target$56 (+73%)$320 (+20%)
StockVane view
StockVane Quant RatingD (33)C (37)
Company
Employees3,5807,928
Founded19922007

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.